宫腔镜子宫内膜电切术对异常子宫出血患者子宫内膜厚度及性激素的影响

doi:10.3760/cma.j.issn.1007-1245.2024.09.017

国际医药卫生导报 ›› 2024, Vol. 30 ›› Issue (9): 1486-1489.DOI: 10.3760/cma.j.issn.1007-1245.2024.09.017

宫腔镜子宫内膜电切术对异常子宫出血患者子宫内膜厚度及性激素的影响

贾明侠魏明明卢云荟

西北大学第一医院妇科，西安　710043

收稿日期:2024-01-30 出版日期:2024-05-01 发布日期:2024-05-30
通讯作者: 魏明明，Email：529042250@qq.com
基金资助:
陕西省科技计划发展项目（2021QJ-421）

Effect of hysteroscopic endometrial resection on endometrial thickness and sex hormones in patients with abnormal uterine bleeding

Jia Mingxia, Wei Mingming, Lu Yunhui

Department of Gynecology, First Hospital, Northwest University, Xi'an 710043, China

Received:2024-01-30 Online:2024-05-01 Published:2024-05-30
Contact: Wei Mingming, Email: 529042250@qq.com
Supported by:
Project of Plan of Science and Technology in Shaanxi (2021QJ-421)

摘要/Abstract

摘要：

目的　探讨宫腔镜子宫内膜电切术对异常子宫出血患者子宫内膜厚度及性激素的影响。方法　选取2020年3月至2023年3月西北大学第一医院收治的130例异常子宫出血患者，通过随机数字表法分为对照组与观察组，各65例。对照组患者年龄（41.18±4.00）岁，病程（15.00±3.58）个月，予以传统刮宫术治疗；观察组患者年龄（41.55±4.44）岁，病程（14.38±3.82）个月，予以宫腔镜子宫内膜电切术治疗。比较两组患者的手术相关指标，治疗前与治疗6个月后的子宫内膜厚度、月经量、性激素水平及不良反应发生情况。采用χ²检验、t检验进行统计分析。结果　观察组肛门排气时间为（4.35±0.85）h、下床活动时间为（8.73±1.52）h、住院时间为（4.15±1.15）d，对照组分别为（7.43±1.82）h、（28.93±3.45）h、（7.43±1.96）d，两组比较差异均有统计学意义（t=12.362、43.198、11.637，均P<0.001）。治疗前，两组患者的子宫内膜厚度、月经量、性激素水平比较差异均无统计学意义（均P>0.05）。治疗6个月后，观察组患者子宫内膜厚度为（6.63±1.33）mm，月经量（91.20±6.83）ml，对照组分别为（7.65±1.35）mm、（101.45±9.82）ml，差异均有统计学意义（t=4.339、6.909，均P<0.001）；观察组黄体生成素（LH）为（9.28±2.45）IU/L、卵泡刺激素（FSH）为（6.30±1.40）IU/L、雌二醇（E2）为（69.03±6.13）pmol/L，对照组分别为（17.89±3.35）IU/L、（16.09±4.16）IU/L、（59.30±5.85）pmol/L，两组比较差异均有统计学意义（t=16.726、17.982、9.258，P<0.001）；观察组不良反应发生率为3.08%（2/65），低于对照组的16.92%（11/65），差异有统计学意义（t=6.923，P=0.009）。结论　宫腔镜子宫内膜电切术治疗可有效降低异常子宫出血患者的子宫内膜厚度和月经量，不影响患者的性激素水平，不良反应发生率低，是一种更安全、有效的治疗选择。

关键词:

异常子宫出血, 宫腔镜子宫内膜电切术, 子宫内膜厚度, 性激素

Abstract:

Objective　To explore the impact of hysteroscopic endometrial resection on endometrial thickness and sex hormones in patients with abnormal uterine bleeding. Methods　One hundred and thirty patients with abnormal uterine bleeding treated at First Hospital, Northwest University from March 2020 to March 2023 were selected for the randomized controlled trial, and were divided into a control group and an observation group by the random number table method, with 65 cases in each group. The control group were (41.18±4.00) years old; their disease course was (15.00±3.58) months. The observation group were (41.55±4.44) years old; their disease course was (14.38±3.82) months. The control group underwent traditional curettage surgery, and the observation group hysteroscopic endometrial electrosurgical resection. The surgical indicators, the endometrial thicknesses, menstrual volumes, and sex hormone levels before and 6 months after the surgery, and the incidences of adverse reactions were compared between the two groups by χ² and t tests. Results　The time to first flatus, time to off bed activity, and hospital stay in the observation group were shorter than those in the control group [(4.35±0.85) h vs. (7.43±1.82) h, (8.73±1.52) h vs. (28.93±3.45) h, and (4.15±1.15) d vs. (7.43±1.96) d], with statistical differences between the two groups (t=12.362, 43.198, and 11.637; all P<0.001). Before the treatment, there were no statistical differences in endometrial thickness, menstrual volume, and sex hormone levels between the two groups (all P>0.05). Six months after the treatment, endometrial thickness, menstrual volume, and levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estradiol (E2) in the observation group were better than those in the control group [(6.63±1.33) mm vs. (7.65±1.35) mm, (91.20±6.83) ml vs. (101.45±9.82) ml, (9.28±2.45) IU/L vs. (17.89±3.35) IU/L, (6.30±1.40) IU/L vs. (16.09±4.16) IU/L, and (69.03±6.13) pmol/L vs. (59.30±5.85) pmol/L], with statistical differences (t=4.339, 6.909, 16.726, 17.982, and 9.258; all P<0.009). The incidence of adverse reactions in the observation group was lower than that in the control group [3.08% (2/65) vs. 16.92% (11/65)], with a statistical difference (t=6.923; P=0.009). Conclusion　Hysteroscopic endometrial resection for patients with abnormal uterine bleeding can effectively reduce their endometrial thickness and menstrual volume and adverse reactions, and does not affect their sex hormone levels, so it is a safe and effective treatment option.

Key words:

Abnormal uterine bleeding, Hysteroscopic endometrial resection, Endometrial thickness, Sex hormones

贾明侠魏明明卢云荟.

宫腔镜子宫内膜电切术对异常子宫出血患者子宫内膜厚度及性激素的影响 [J]. 国际医药卫生导报, 2024, 30(9): 1486-1489.

Jia Mingxia, Wei Mingming, Lu Yunhui.

Effect of hysteroscopic endometrial resection on endometrial thickness and sex hormones in patients with abnormal uterine bleeding [J]. International Medicine and Health Guidance News, 2024, 30(9): 1486-1489.

参考文献

[1] 唐卉,王惠云,张汝坚.TCRE治疗功能失调性子宫出血的效果及对激素水平的影响[J].黑龙江中医药,2018,48(3):69-71.
[2] 邱慧英.宫腔镜子宫内膜电切术治疗功能性子宫出血的远期效果观察[J].当代医学,2018,24(35):38-40.DOI:10.3969/j.issn.1009-4393.2018.35.014.
[3] 弓丽丽.宫腔镜电切术结合米非司酮治疗围绝经期功能失调性子宫出血疗效观察[J].黑龙江医学,2021,45(23):2509-2510.DOI:10.3969/j.issn.1004-5775.2021.23.018.
[4] 叶淑珠.诺舒子宫内膜切除术与经宫颈子宫内膜电切术治疗功能失调性子宫出血的比较[J].实用医学杂志,2016,32(12):2001-2003.DOI:10.3969/j.issn.1006-5725. 2016.12.033.
[5] 刘智霞.经阴道超声及宫腔镜检查在异常子宫出血诊断中的应用价值研究[J].国际医药卫生导报,2017,23(10):1590-1592.DOI:10.3760/cma.j.issn.1007-1245. 2017.10.039.
[6] 甄璟然,郁琦.«功能失调性子宫出血临床诊疗指南»解读[J]. 中国全科医学(医生读者版),2009(5):8-10.
[7] 黄颖,高波,李玲. 两种方法治疗青春期功能失调性子宫出血98例临床疗效分析[J]. 海军医学杂志,2016,37(2):170-171,172. DOI:10.3969/j.issn.1009-0754.2016.02.025.
[8] 吴利萍,侯伟涛,牛三强,等. 宫腔镜下电切术联合GnRH-a在子宫黏膜下肌瘤异常子宫出血患者中的研究[J]. 中国性科学,2021,30(2):92-96. DOI:10.3969/j.issn.1672-1993. 2021.02.028..
[9] 沈育红,刘延,龙雯晴. 左炔诺孕酮宫内节育系统联合宫腔镜子宫内膜电切术治疗围绝经期异常子宫出血的临床疗效及安全性评价[J]. 临床和实验医学杂志,2021,20(2):197-200. DOI:10.3969/j.issn.1671-4695.2021.02.024.
[10] 余婧,董玉琼,徐静,等. 宫腔镜电切术联合醋酸甲地孕酮治疗围绝经期异常子宫出血疗效观察[J]. 海南医学,2022,33(7):883-886. DOI:10.3969/j.issn.1003-6350. 2022.07.017..
[11] 王琪. 诺舒阻抗控制子宫内膜切除系统治疗功能失调性子宫出血的疗效及安全性[J]. 当代医学,2018,24(15):113-115. DOI:10.3969/j.issn.1009-4393.2018.15.048.
[12] 张海敏,张海琴. 米非司酮预防功能失调性子宫出血子宫内膜息肉宫腔镜治疗后复发的效果研究[J]. 中国药物与临床,2019,19(20):3580-3581. DOI:10.11655/zgywylc2019. 20.054.
[13] 郭杰. 宫腔镜子宫内膜射频消融术治疗围绝经期功血的临床疗效及安全性观察[J]. 中国临床新医学,2018,11(10):1027-1030. DOI:10.3969/j.issn.1674-3806.2018.10.20.
[14] 王芝英. 诺舒子宫内膜去除系统对功能失调性子宫出血患者疗效及血清性激素水平的影响[J]. 中国妇幼保健,2018,33(23):5316-5319. DOI:10.7620/zgfybj.j.issn.1001-4411. 2018.23.05.
[15] 曹爱娣,何耀娟,肖青,等. 宫腔镜电切术联合米非司酮治疗围绝经期功能失调性子宫出血患者的疗效观察[J]. 医学临床研究,2018,35(8):1586-1588. DOI:10.3969/j.issn. 1671-7171.2018.08.044.
[16] 付芳,周群英.宫腔镜下热球消融术在围绝经期功血中的应用效果观察[J].现代科学仪器,2021,38(4):169-172.
[17] 冯晔.试析宫腔镜子宫内膜电切术治疗功能失调性子宫出血的临床效果及对卵巢功能的影响[J].黑龙江医学,2019,44(9):1040-1041.DOI:10.3969/j.issn.1004-5775. 2019.09.018.
[18] 芦军军. 宫腔镜子宫内膜电切术治疗难治性功能失调性子宫出血患者的效果观察[J]. 实用临床医药杂志,2020,24(5):117-120. DOI:10.7619/jcmp.202005032.
[19] 刘鹤. 宫腔镜子宫内膜电切术治疗功能失调性子宫出血的效果及对卵巢功能的影响[J]. 临床医学,2020,40(1):68-70. DOI:10.19528/j.issn.1003-3548.2020.01.028.
[20] 刘雁林,陈海燕,王沛靓,等. 宫腔镜子宫内膜电切术治疗功能失调性子宫出血的疗效及对患者性激素水平的影响[J]. 现代生物医学进展,2019,19(13):2567-2570,2582. DOI:10.13241/j.cnki.pmb.2019.13.038.
[21] 李幔.甲地孕酮联合宫腔镜手术对异常子宫出血患者性激素水平、子宫内膜厚度及复发的影响[J].哈尔滨医药,2024,44(1):65-67.DOI:10.3969/j.issn.1001-8131. 2024.01.021.

宫腔镜子宫内膜电切术对异常子宫出血患者子宫内膜厚度及性激素的影响

Effect of hysteroscopic endometrial resection on endometrial thickness and sex hormones in patients with abnormal uterine bleeding

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	刘安娜张玲. 解脲支原体感染对不育男性精液质量及性激素水平的影响 [J]. 国际医药卫生导报, 2024, 30(9): 1532-1534.
[2]	吴晓荣詹萌曹意苒. 戊酸雌二醇片联合二甲双胍治疗不孕症患者的效果 [J]. 国际医药卫生导报, 2024, 30(7): 1186-1189.
[3]	刘安娜, 王琛. 131例肥胖不育男性患者精液质量及性激素水平分析[J]. 国际医药卫生导报, 2022, 28(9): 1267-1269.
[4]	王敏侠, 刘杨, 于汉凤. TCRP联合亮丙瑞林用于子宫内膜息肉患者对性激素水平及术后复发的影响[J]. 国际医药卫生导报, 2022, 28(3): 399-402.